Modeling the use of SARS-CoV-2 vaccination to safely relax non-pharmaceutical interventions
Preprint
Abstract
In response to the COVID-19 pandemic, widespread non-pharmaceutical interventions (NPIs), including physical distancing, mask wearing, and enhanced hygiene, have been implemented. As of March 2021, three effective vaccines have been approved for emergency use in the United States, with several other vaccines in the pipeline. We use a transmission model to study when and how NPIs could be relaxed in the United States with relative safety as vaccination becomes more widespread. We compare different relaxation scenarios where NPIs begin to relax 0-9 months after vaccination begins for both a one dose and two dose strategy, with historical levels of social interactions being reached within 1 month to 1 year. In our model, vaccination can allow widespread relaxation of NPIs to begin safely within 2 to 9 months, greatly reducing deaths and peak health system burden compared to relaxing NPIs without vaccination. Vaccinated individuals can safely begin to relax NPIs sooner than unvaccinated individuals. The extent of delay needed to safely reopen depends primarily on the rate of vaccine rollout, with the degree of protection against asymptomatic infection playing a secondary role. If a vaccination rate of 3 million doses/day can be achieved, similar to the typical rollout speed of seasonal influenza vaccination, NPIs could begin to be safely relaxed in 2-3 months. With a vaccination rate of 1 million doses/day, a 6–9-month delay is needed. A one dose strategy is preferred if relative efficacy is similar to a two-dose series, but the relative benefit of this strategy is minimal when vaccine rollout is fast. Due to the urgent need to pursue strategies that enable safe relaxation of NPIs, we recommend a two-dose strategy with an initial delay of at least 3 months in relaxing restrictions further, and that the speed of vaccine rollout be given immediate priority.Keywords
This publication has 31 references indexed in Scilit:
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic periodScience, 2020
- Early transmission dynamics and control of COVID-19 in a southern hemisphere setting: Lima-Peru, February 29 th -March 30 th , 2020medRxiv, 2020
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and ApplicationAnnals of Internal Medicine, 2020
- Modeling serological testing to inform relaxation of social distancing for COVID-19 controlmedRxiv, 2020
- The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreakScience, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- Projecting social contact matrices in 152 countries using contact surveys and demographic dataPLOS Computational Biology, 2017
- Fractional dosing of yellow fever vaccine to extend supply: a modelling studyThe Lancet, 2016
- One versus two doses: What is the best use of vaccine in an influenza pandemic?Epidemics, 2015
- Study Designs for Evaluating Different Efficacy and Effectiveness Aspects of VaccinesAmerican Journal of Epidemiology, 1997